-
Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer
Slapak, E. J., el Mandili, M., Brink, M. S. T., Kros, A., Bijlsma, M. F. & Spek, C. A., 1 Jul 2023, In: International journal of molecular sciences. 24, 13, 10704.Research output: Contribution to journal › Article › Academic › peer-review
-
Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview
Slapak, E. J., el Mandili, M., Bijlsma, M. F. & Spek, C. A., 1 Feb 2022, In: Pharmaceutics. 14, 2, 390.Research output: Contribution to journal › Review article › Academic › peer-review
-
Adam9-responsive mesoporous silica nanoparticles for targeted drug delivery in pancreatic cancer
Slapak, E. J., Kong, L., Mandili, M. E., Nieuwland, R., Kros, A., Bijlsma, M. F. & Arnold Spek, C., 1 Jul 2021, In: Cancers. 13, 13, 3321.Research output: Contribution to journal › Article › Academic › peer-review
- All publications